 |
| MAY
5, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
 |
The
Most Trusted Contract Vivarium
in Every Bio Hub
Opening in San Diego Fall 2026 |
|
Learn More
→ |
|
|
- Bionano:
56% Increase in Publications Describing the
Utility of OGM in Rare Diseases in Q1 2026 vs
Q1 2025 More
- Epirium
Bio: Presenting New Preclinical Data on Its
15-PGDH Inhibitor Program in Inflammatory
Bowel Disease at Digestive Disease Week 2026 More
- Fate
Therapeutics: Selected for U.S. FDA
Chemistry, Manufacturing, and Controls
Development and Readiness Pilot Program to
Support Manufacturing Readiness of FT819 More
- ImpediMed:
Broadens Breast Cancer Survivorship Monitoring
With the SOZO Digital Health Platform at ASBrS
2026 More
- Neurocrine
Biosciences: New Survey Results Showing
Significant Burden of Tardive Dyskinesia on
Employment More
- Senhwa
Biosciences: Launches Global Study, Targeting
Breakthrough in Hard-to-Treat Cancers With
CX-5461 and Tislelizumab Combination More
- Zentalis
Pharmaceuticals: First Patient Dosed in
ASPENOVA Phase 3 Trial of Azenosertib in
Patients With Cyclin E1-Positive
Platinum-Resistant Ovarian Cancer More
|
|
 |
|
Investment Banking Advisory to the
Life Science Industry |
|
Learn More
→ |
|
|
- Biocentury: Ep. 364 - UCB's Candid Buy,
Grand Rounds and Leukodystrophies Podcast
- Gene Therapy and Vectors R&D
Partnerships, M&A and Venture Funding –
2025 Review More
- More on UCB Inking $2B Candid Buyout to Join
Gilead in Autoimmune Field More
More
More
- ORIC Pharmaceuticals: First Quarter 2026
Financial Results and Operational Updates More
- Sanford Burnham Prebys: Awarded $3.9
Million NIH Grant to Develop First-in-Class
Non-Opioid Pain Treatment More
- Travere Therapeutics: First Quarter 2026
Financial Results More
|
|
 |
| San
Diego's turnkey, rentable vivarium
lab space: Start with a few cages
and grow. |
|
Learn More
→ |
|
|
- Cardiff Insights: Life
Sciences Intelligence for the Week More
- Oncodesign Services: Extends
Collaboration With GIP ARRONAX to Strengthen
Astatine-211 Supply for Targeted Alpha
Radiotherapy More
- Subscribe to LifeSci Startup for
Updates on US Startups More
- Top Medtech Executive Moves in 2026 More
|
|
 |
| Life
Sciences Talent and Consulting
Strategist George Quinn Named
Partner, Fractional Talent at
Slone Partners |
|
Learn More
→ |
|
|
- AI in Biotech: The New Frontier for
Leadership & Strategy More
- Biopharmas Pull Back on Layoffs in Q1 More
- Collective Minds: The
First Executive Hire - What Early-Stage
Founders Get Right—and Wrong More
- Empowering Students through STEM: A
Conversation With Massachusetts Science &
Engineering Fair Executive Director Helen
Rosenfeld More
- From Seed to Series C: What
Investors Look for Beyond the Science More
- How Industry Trends are Impacting Hiring
Decisions and Leadership Strategies in Life
Sciences More
- M&A in Life Sciences: The Turning Tide –
Why Now is a Strategic Inflection for
Biopharma and Biotech More
- Novo’s Double Departures: As GLP-1 Luminary
Retires, an Obesity Leader Goes to Boehringer
Ingelheim More*
- More Than Executive Search: Building
Leadership for Every Stage of Growth More
- Telling Your Science Story to Investors More
- Top 10 High-Impact Careers Defining the
Future of Life Sciences More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: San Diego Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:San
Diego, all rights reserved
2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
